New study aims to sharpen dengue diagnosis
NCT ID NCT07203183
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study will collect blood samples from 200 people aged 12 and older who either have or do not have dengue. The goal is to use these samples to develop and improve diagnostic tests for dengue. Participants must have symptoms consistent with dengue and cannot have been vaccinated for the disease or be in other clinical trials.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to more accurate and faster dengue diagnostic tests.
- What could go wrong
- This is a sample collection study, not a treatment trial. It does not test any new therapy or vaccine.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 200 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Oct 2025
An estimate. Start dates often move.
- Expected to finish
-
Apr 2026
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Subjects with symptoms suggestive of active dengue or a recent diagnosis of dengue seeking clinical care.
- Ages
-
12 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age ≥12-years-old * Individuals suspected or confirmed for active dengue, with dengue-consistent symptoms onset up to and including 10 days before enrolment in this trial. Exclusion Criteria: * Subject has been vaccinated for dengue. * Subject participates in an investigative drug, vaccine or medical device clinical study * Participant is deemed unfit for the study by the Investigator * Participant is unwilling or unable to provide informed consent
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Dengue are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The study's own enquiry address
This study publishes an address for enquiries. See it below .
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Why does dengue put some people in the hospital? scientists track 258 patients to find out
- Can a digital assistant and quick tests stop unnecessary antibiotics for kids?
- Can a digital assistant help clinics catch dengue fever faster?
- Can detailed tracking of dengue patients sharpen the next generation of clinical trials?
- Scientists deliberately infect volunteers with dengue to unlock immune secrets
- Could papaya leaves help fight dengue? new trial tests the idea